esgrev_escmid Profile Banner
ESGREV Profile
ESGREV

@esgrev_escmid

Followers
302
Following
577
Statuses
786

ESCMID Study Group for Respiratory Viruses

Joined January 2021
Don't wanna be here? Send us removal request.
@esgrev_escmid
ESGREV
2 years
Are you a specialist interested in joining @esgrev_escmid , the #respiratory #virus study group of @ESCMID ? Join us before the year’s end! We look forward to working together in 2023 and beyond! 🛎here is what you need to do 👇
0
5
7
@esgrev_escmid
ESGREV
2 days
RT @rivereuproject: How does an underserved ethnic minority achieve high vaccination rates? Our latest publication explores how trust, c…
0
3
0
@esgrev_escmid
ESGREV
2 days
RT @gavi: Preventing infections could be key to preventing #dementia. Routine #vaccines like the flu shot and diphtheria vaccine could redu…
0
29
0
@esgrev_escmid
ESGREV
2 days
RT @ImmuHubs: Reminder of the importance of staying vigilant: #UnitedInProtection
0
3
0
@esgrev_escmid
ESGREV
6 days
RT @seki_eu: Great ID Podcast! 👇
0
1
0
@esgrev_escmid
ESGREV
6 days
RT @CIDJournal: Executive Summary: State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections 🔗
0
37
0
@esgrev_escmid
ESGREV
11 days
RT @ESCMID: The #ESCMIDGlobal 2025 Art Gallery is now available on our website! Check out all of the incredible art that we received from y…
0
3
0
@esgrev_escmid
ESGREV
11 days
RT @OliverVarhelyi: Pleased to deliver keynote address at the #EUHealthSummit. Let us reshape together the future of health in Europe. @Vis
0
10
0
@esgrev_escmid
ESGREV
11 days
RT @EU_Health: A new joint action focusing on tackling chronic respiratory diseases – JARED - is launching today. Backed by #EU4Health, the…
0
11
0
@esgrev_escmid
ESGREV
11 days
RT @ECDC_EU: There is currently significant respiratory virus activity in the EU/EEA, with both #influenza & #RSV epidemics ongoing. #Vacc
0
14
0
@esgrev_escmid
ESGREV
15 days
🛎️ Check out the @ESCMID educational program here 👇
@ESCMID
ESCMID
15 days
There are more ESCMID Courses available for registration. Be sure to check the list of available courses and sign up for the ones that interest you. Attendance grants are also available for selected courses so don't miss your chance to apply!
Tweet media one
0
1
2
@esgrev_escmid
ESGREV
15 days
RT @ImmuHubs: Interesting! 👇
0
1
0
@esgrev_escmid
ESGREV
15 days
RT @NFIDVaccines: Although #RSV is typically associated with young children, it can also impact older adults. Each year in the US, RSV is e…
0
5
0
@esgrev_escmid
ESGREV
17 days
RT @ESWInfluenza: 📩 #ESWI Monthly #H5N1 Spotlight is here! ℹ️ Informative series providing a thorough and accurate set of scientific artic…
0
2
0
@esgrev_escmid
ESGREV
17 days
RT @seki_eu: 👇
0
1
0
@esgrev_escmid
ESGREV
17 days
RT @ERASMUS_MedLit: Meanwhile. Antibiotics are given too frequently… #AMR #Influenza
0
1
0
@esgrev_escmid
ESGREV
17 days
RT @ESOTtransplant: CMV infection = leading opportunistic infection after transplantation. 💡 What happens when treatment gets tricky? Find…
0
6
0
@esgrev_escmid
ESGREV
17 days
Sadly, not surprising at all.. @AAPNews @PIDSociety @EAPCongress
@CDCFlu
CDC Flu
2 months
CDC co-authored surveillance study found only half of children hospitalized with #flu received CDC-recommended antiviral treatment, which can lessen symptoms and prevent serious flu complications. Read study:
Tweet media one
0
0
0
@esgrev_escmid
ESGREV
21 days
RT @gavi: What does it take to deploy a new vaccine during a deadly outbreak to millions of people? In Niger, deploying a familiar data man…
0
20
0
@esgrev_escmid
ESGREV
22 days
RT @ESCMID: Don't miss out on the best prices for #ESCMIDGlobal 2025! The early bird discount ends on 5 February so be sure to grab your re…
0
3
0
@esgrev_escmid
ESGREV
22 days
RT @MarilyneDaher1: Real-world experience of maribavir in the treatment of CMV in HCT recipients and patients with HM, published in @TheTxI
0
6
0